[Federal Register Volume 88, Number 160 (Monday, August 21, 2023)]
[Notices]
[Pages 56846-56847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17914]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Advisory Board.
The meeting will be held as a virtual meeting and is open to the
public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: http://videocast.nih.gov/.
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended for the
review, discussion, and evaluation of intramural programs and projects
conducted by the National Cancer Institute, including consideration of
research scientist qualifications and the overall competence of those
investigators to conduct research, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy. In
addition, the grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Date: September 6, 2023.
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Director's and Program reports and presentations;
business of the Board.
Closed: 4:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Closed: 5:00 p.m. to 6:00 p.m.
Agenda: Review of intramural leadership of clinical and basic
research efforts and the discussion of other related confidential
personnel issues.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Room 7W444,
[[Page 56847]]
Bethesda, MD 20892, 240-276-6340, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm, where an agenda, instructions for accessing the
virtual NCAB meetings, and any additional information for the
meetings will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 16, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17914 Filed 8-18-23; 8:45 am]
BILLING CODE 4140-01-P